Construction of tissue-engineered composite intervertebral disc and preliminary morphological and biochemical evaluation

Biochemical and Biophysical Research Communications

Volumn 407, Issue 2, 2011, Pages 327-332

  Zhuang, Y ^a   Huang, B ^a   Li, C Q ^a   Liu, L T ^a   Pan, Y ^a   Zheng, W J ^a   Luo, G ^a   Zhou, Y ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Annulus fibrosus; Composite; Degenerative disc disease; Nucleus pulposus; Tissue engineering

Indexed keywords

CHONDROITIN 6 SULFATE; COLLAGEN TYPE 2; HYALURONIC ACID; HYDROXYPROLINE; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; BONE MATRIX; COMPOSITE MATERIAL; CONTROLLED STUDY; DEMINERALIZATION; DNA CONTENT; INTERVERTEBRAL DISK; MORPHOLOGY; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEUS PULPOSUS; NUDE MOUSE; PRIORITY JOURNAL; TISSUE ENGINEERING;

ANIMALS; CHONDROITIN SULFATES; COLLAGEN TYPE II; DNA; GELATIN; HYALURONIC ACID; INTERVERTEBRAL DISK; MICE; MICE, NUDE; RABBITS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

MUS;

EID: 79953712280     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.015     Document Type: Article

References (26)

1. Devereaux M. Low back pain. Med. Clin. North Am. 2009, 93:477-501.
2. Lotz J.C., Chin J.R. Intervertebral disc cell death is dependent on the magnitude and duration of spinal loading. Spine 2000, 25:1477-1483.
3. Yasuma T., Koh S., Okamura T., Yamauchi Y. Histological changes in aging lumbar intervertebral discs. Their role in protrusions and prolapses. J. Bone Joint Surg. Am. 1990, 72:220-229,.
4. Bao Q.B., Yuan H.A. New technologies in spine: nucleus replacement. Spine 2002, 27:1245-1247.
5. Nomura T., Mochida J., Okuma M., Nishimura K., Sakabe K. Nucleus pulposus allograft retards intervertebral disc degeneration. Clin. Orthop. Relat. Res. 2001, 8:94-101.
6. David T. Long-term results of one-level lumbar arthroplasty: minimum 10-year follow-up of the CHARITE artificial disc in 106 patients. Spine 2007, 32:661-666.
7. Van Ooij A., Oner F.C., Verbout A.J. Complications of artificial disc replacement: a report of 27 patients with the SB Charite disc. J. Spinal Disord. Technol. 2003, 16:369-383.
8. Paesold G., Nerlich A.G., Boos N. Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur. Spine J. 2007, 16:447-468.
9. Kandel R., Roberts S., Urban J.P. Tissue engineering and the intervertebral disc: the challenges. Eur. Spine J. 2008, 17:480-491.
10. Li C.Q., Huang B., Luo G., Zhang C.Z., Zhuang Y., Zhou Y. Construction of collagen II/hyaluronate/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering and preliminary analysis of its physico-chemical properties and biocompatibility. J. Mater. Sci. Mater. Med. 2010, 21:741-751.
11. Huang B., Li C.Q., Zhou Y., Luo G., Zhang C.Z. Collagen II/hyaluronan/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering. J. Biomed. Mater. Res. B Appl. Biomater. 2010, 92:322-331.
12. Pan Y., Dong S.W., Hao Y., Chu T.W., Li C.Q., Zhang Z.F., et al. Demineralized bone matrix gelatin as scaffold for tissue engineering. Afr. J. Microbiol. Res. 2010, 4:865-870.
13. Kim Y.J., Sah R.L., Doong J.Y. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal. Biochem. 1988, 174:168-176.
14. Enobakhare B.O., Bader D.L., Lee D.A. Quantification of sulfated glycoaminoglycans in chondrocyte/alginate culture, by use of 1,9-dimethylmethylene blue. Anal. Biochem. 1996, 243:189-191.
15. Stegman H., Stalder K. Determination of hydroxyproline. Clin. Chem. Acta 1967, 18:267-273.
16. Kalson N.S., Richardson S., Hoyland J.A. Strategies for regeneration of the intervertebral disc. Regen. Med. 2008, 3:717-729.
17. Horner H.A., Roberts S., Bielby R.C., Menage J., Evans H., Urban J.P. Cells from different regions of the intervertebral disc: effect of culture system on matrix expression and cell phenotype. Spine 2002, 27:1018-1028.
18. Roberts S., Evans H., Trivedi J., Menage J. Histology and pathology of the human intervertebral disc. J. Bone Joint Surg. Am. 2006, 88:433-438.
19. Li X., Jin L., Balian G., et al. Demineralized bone matrix gelatin as scaffold for osteochondral tissue engineering. Biomaterials 2006, 27:2426-2433.
20. Wang Y., Feng G., Shen F.H., Laurencin C.T., Li X. Biphasic scaffold for annulus fibrosus tissue regeneration. Biomaterials 2008, 29:643-652.
21. Mizuno H., Roy A.K., Vacanti C.A., Kojima K., Ueda M., Bonassar L.J. Tissue-engineered composites of anulus fibrosus and nucleus pulposus for intervertebral disc replacement. Spine 2004, 29:1290-1297.
22. Mizuno H., Roy A.K., Zaporojan V., Vacanti C.A., Ueda M., Bonassar L.J. Biomechanical and biochemical characterization of composite tissue-engineered intervertebral discs. Biomaterials 2006, 27:362-370.
23. Nesti L.J., Li W.J., Shanti R.M., Jiang Y.J., Jackson W., Freedman B.A., et al. Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng. Part A 2008, 14:1527-1537.
24. Charulatha V., Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 2003, 24:759-767.
25. Peretti G.M., Zaporojan V., Spangenberg K.M., Randolph M.A., Fellers J., Bonassar L.J. Cell-based bonding of articular cartilage: an extended study. J. Biomed. Mater. Res. 2003, 64:517-524.
26. Masuda K., An H.S. Prevention of disc degeneration with growth factors. Eur. Spine J. 2006, 15:422-430.